A comparison of fentanyl with pethidine for pain relief during childbirth.
Obstetric analgesia: A comparison of intranasal or subcutaneously administered fentanyl with intramuscular administered pethidine in labour and its effects on mother and baby.
Flinders University
150 participants
May 1, 2010
Interventional
Conditions
Summary
Pethidine is currently the most widely used narcotic administered systemically for the relief of labour pain, but has been shown to have numerous side effects on both mother and neonate. An alternative narcotic, fentanyl when administered intravenously (IV) has been shown to have fewer side effects and a shorter duration of action than does pethidine. There is a lack of research relating to the use of fentanyl administered during labour via alternative routes. Alternative routes have the benefit of being less invasive, requires fewer resources and provides more autonomy to the midwife providing care. This has particular benefits for rural and remote birthing communities. This study will examine the safety and efficacy of fentanyl administered by intranasal (IN) or subcutaneous (s.c) routes for pain relief during childbirth for both mother and neonate. It also will investigate possible maternal and neonatal side effects. Outcomes will be compared with intramuscular (IM) pethidine.
Eligibility
Inclusion Criteria1
- Healthy women birthing at term (between 37 to 42 weeks gestation). The woman must be in active labour, having regular contractions and a cervical dilatation of at least 3cm.
Exclusion Criteria1
- Women with a substance abuse history (opioid tolerance), premature labour, bronchial asthma, a drug allergy or history of hypersensitivity to opioid substances or women who are taking or have taken Monoamine oxidase inhibitors (MAOI), Selective Serotonin Reuptake Inhibitors (SSRI’s) or tricyclics within the previous fourteen days.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will be randomised into one of three groups. Group 1. Self administered intranasal fentanyl, under supervision of a midwife. Group 2. Fentanyl administered subcutaneously Group 3. Pethidine administered intramuscularly
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609001027202